As of 10:51am ET
| -0.44 / -2.95%|
The 6 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 30.50, with a high estimate of 51.65 and a low estimate of 10.95. The median estimate represents a +110.48% increase from the last price of 14.49.
The current consensus among 6 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.